What's new

EMEA-003466-PIP01-23

EMEA-003466-PIP01-23

Mar 7, 2025 - 13:33
 0
EMEA-003466-PIP01-23
EMEA-003466-PIP01-23
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Supemtek Tetra (previo...

Next Article

Masdar subsidiary to build 130MW solar PV plant in Bulgaria

Related Posts

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

PSUSA/00010199/202405

PSUSA/00010199/202405

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0